AURA
Price
$5.96
Change
+$0.03 (+0.51%)
Updated
May 21 closing price
Capitalization
369.55M
77 days until earnings call
ORIC
Price
$5.87
Change
+$0.20 (+3.53%)
Updated
May 21 closing price
Capitalization
403.07M
77 days until earnings call
Interact to see
Advertisement

AURA vs ORIC

Header iconAURA vs ORIC Comparison
Open Charts AURA vs ORICBanner chart's image
Aura Biosciences
Price$5.96
Change+$0.03 (+0.51%)
Volume$246.09K
Capitalization369.55M
Oric Pharmaceuticals
Price$5.87
Change+$0.20 (+3.53%)
Volume$1.19M
Capitalization403.07M
AURA vs ORIC Comparison Chart
Loading...
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AURA vs. ORIC commentary
May 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AURA is a Hold and ORIC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 22, 2025
Stock price -- (AURA: $5.96 vs. ORIC: $5.87)
Brand notoriety: AURA and ORIC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AURA: 78% vs. ORIC: 152%
Market capitalization -- AURA: $369.55M vs. ORIC: $403.07M
AURA [@Biotechnology] is valued at $369.55M. ORIC’s [@Biotechnology] market capitalization is $403.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AURA’s FA Score shows that 0 FA rating(s) are green whileORIC’s FA Score has 1 green FA rating(s).

  • AURA’s FA Score: 0 green, 5 red.
  • ORIC’s FA Score: 1 green, 4 red.
According to our system of comparison, both AURA and ORIC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AURA’s TA Score shows that 6 TA indicator(s) are bullish while ORIC’s TA Score has 5 bullish TA indicator(s).

  • AURA’s TA Score: 6 bullish, 2 bearish.
  • ORIC’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, AURA is a better buy in the short-term than ORIC.

Price Growth

AURA (@Biotechnology) experienced а +21.63% price change this week, while ORIC (@Biotechnology) price change was +20.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.17%. For the same industry, the average monthly price growth was +6.77%, and the average quarterly price growth was -1.67%.

Reported Earning Dates

AURA is expected to report earnings on Aug 07, 2025.

ORIC is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORIC($403M) has a higher market cap than AURA($370M). ORIC (-27.261) and AURA (-27.494) have similar YTD gains . AURA has higher annual earnings (EBITDA): -91.84M vs. ORIC (-145.48M). ORIC has more cash in the bank: 204M vs. AURA (174M). ORIC has less debt than AURA: ORIC (3.21M) vs AURA (19.1M). AURA (0) and ORIC (0) have equivalent revenues.
AURAORICAURA / ORIC
Capitalization370M403M92%
EBITDA-91.84M-145.48M63%
Gain YTD-27.494-27.261101%
P/E RatioN/AN/A-
Revenue00-
Total Cash174M204M85%
Total Debt19.1M3.21M594%
TECHNICAL ANALYSIS
Technical Analysis
AURAORIC
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bullish Trend 1 day ago
69%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
83%
Declines
ODDS (%)
Bearish Trend 9 days ago
83%
Bearish Trend 7 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
81%
Aroon
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SOAVX33.27N/A
N/A
Spirit of America Large Cap Value A
FASPX44.28N/A
N/A
Fidelity Advisor Value Strategies M
CHUCX25.08N/A
N/A
Alger Global Equity C
KSOCX174.40N/A
N/A
Kinetics Small Cap Opportunities Adv C
AEIYX8.66N/A
N/A
American Century Equity Income Y

AURA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AURA has been loosely correlated with MGTX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if AURA jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AURA
1D Price
Change %
AURA100%
+0.51%
MGTX - AURA
47%
Loosely correlated
-3.64%
ORIC - AURA
47%
Loosely correlated
+3.53%
VRDN - AURA
47%
Loosely correlated
-1.16%
BEAM - AURA
47%
Loosely correlated
-2.99%
CCCC - AURA
45%
Loosely correlated
-8.11%
More

ORIC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORIC has been loosely correlated with KYMR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ORIC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORIC
1D Price
Change %
ORIC100%
+3.53%
KYMR - ORIC
54%
Loosely correlated
-4.17%
IDYA - ORIC
49%
Loosely correlated
-2.45%
AURA - ORIC
48%
Loosely correlated
+0.51%
CCCC - ORIC
48%
Loosely correlated
-8.11%
SNDX - ORIC
46%
Loosely correlated
+0.76%
More